Today: Tue 7 Jul 2015
Register & Login:  Register
   Login
Register Login

heart failure

The following articles have the tag heart failure

Heart risks with DPP-4 inhibitors unfounded?

Heart risks with DPP-4 inhibitors unfounded?

CONCERN over DPP-4 inhibitors being linked to heart failure has been eased by the results of two new trials, experts say. An Italian case-control study of 282,000 people on diabetes medication found no increased risk of hospitalisation for heart failure, and a 6% lower risk of all-cause mortality, associated with a range of DPP-4 inhibitors. And the TECOS randomised controlled trial (RCT) of 15,000 patients with cardiovascular disease found that adding sitagliptin to usual care was not linked to hospitalisation for heart failure or major CVD events. There have now been three major RCTs, in addition ...

High-dose vitamins can pose extra risk

High-dose vitamins can pose extra risk

UNNECESSARY supplementation with high-dose vitamins should be discouraged in patients with metabolic syndrome as it can promote oxidative stress, a researcher says. GP Dr Anne-Thea McGill, an obesity researcher in the department of general practice and primary healthcare at the University of Auckland, says that while correcting a true deficiency reduces disease, high-dose vitamins may make certain conditions, including heart failure and diabetes, worse. "We should not be giving high-dose vitamins to anybody, particularly type 2 diabetics, who have increased oxidative stress,” she told the Australian and New Zealand Eating Disorders and Obesity conference at Surfers Paradise. ...

Daily tipple cuts heart risk

A SMALL glass of wine per day could cut a person’s risk of heart failure by a fifth, and is associated with better outcomes than abstaining entirely, a large US study suggests.

More heart failure vigilance needed

More heart failure vigilance needed

GPs should have a high index of suspicion when it comes to early detection of heart failure, a leading Melbourne cardiologist says.

CV deaths spark TGA drug review

THE TGA will review the drug ivabradine (Coralan, Servier), which is PBS listed for chronic heart failure, after an increased risk of cardiovascular death and non-fatal myocardial infarction was detected in a clinical trial.

Heart drug scrutiny after rise in mortality risk

THE TGA will review the drug ivabradine (Coralan, Servier), which is PBS listed for chronic heart failure, after an increased risk of cardiovascular death and non-fatal myocardial infarction was detected in a clinical trial.

World-first artificial heart transplant patient dies

A SEPTUAGENARIAN man who was fitted with the French biomedical firm Carmat's first artificial heart two-and-half months ago has died.

Heart failure risk rises with BMI increase

Heart failure risk rises with BMI increase

OBESITY is causally linked to heart failure, with every unit increment in BMI increasing the risk by nearly 20%, according to an international analysis.

Make CoQ10 standard for heart failure: study

COENZYME Q10 (CoQ10) should be added to standard chronic heart failure (CHF) therapy, according to researchers who found it halved all-cause mortality in a clinical trial.

GP puts her heart into checkups

GP puts her heart into checkups

A DIAGNOSIS of heart failure at the age of 40 has made Sydney GP Dr Joanna (Jodie) Emanuel passionate about raising awareness of heart disease in women and has influenced the way she practises.

New guide clarifies role of ablation in AF

THE increasing prevalence of atrial fibrillation (AF), together with some confusion about the optimal use of catheter ablation, has prompted the development of Australia’s first consensus statement to guide treatment of AF.

New guide clarifies catheter ablation

CONFUSION about the optimal use of catheter ablation and the increasing prevalence of atrial fibrillation (AF) has prompted the development of Australia’s first consensus statement to guide treatment.

OSA in elderly raises CV death risk

ELDERLY people with untreated severe obstructive sleep apnoea (OSA) are at a higher risk of dying from stroke or heart failure, a prospective study shows.

Movement disorder drug linked to heart failure

A POSSIBLE increased risk of heart failure has been linked by the US Food and Drug Administration to the movement disorders drug pramipexole.

Heart failure compromises cognitive skills

SIMPLE and clear therapeutic regimens are needed for patients with heart failure, as the condition compromises cognitive function, Australian researchers say.

Antidepressant unsuccessful in heart failure

THE use of an SSRI in patients with heart failure and depression has failed to show a significant reduction in depressive symptoms or improvement in cardiovascular status. US researchers randomised 469 patients with heart failure and major depressive disorder to either sertraline (50-200 mg a day) or a matching placebo.  After 12 weeks, both groups recorded similar reductions in depression severity and improvements in cardiovascular outcomes. About 69% of patients in both groups recorded some level of cardiovascular improvement. Professor Henry Krum, director of the Centre of Cardiovascular Research and Education in Therapeutics at Monash University, ...

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement